Historic

2002

The year of 2002 was marked by  the founding of Radiopharmacus – Solutions in Nuclear Medicine, specialized in provide consulting services in hospital radiopharmacy.

2004

In 2004, by investing in technology with a view to offering innovative solutions for the market, the company moved to TECNOPUC – PUC/RS (located in Porto Alegre, Rio Grande do Sul state, Brazil), ones of the largest technology parks in Latin America.

2008

Started  Cold Kits manufacturing in an industrial scale.

2011

First round of Venture Capital investment.

2012

Investment in the new brand: we become the RPH Group.

In the same year RPH Group has set partnership  with ITG (Isotope Technologies Garching), introducing the new Ga-68 technology in the Brazilian nuclear medicine market.

 

 

2014

In 2014 the company’s manufacturing plant obtained GMP certification (Good Manufacturing Practices), becoming the first in its sector to achieve this certification  according to national legislation.

2015

Portfolio within the regulatory requirements of ANVISA, including Lantheus generator.

2018

RPHOSTEO (medronic acid) is the first Cold Kit to receive a market authorization in the history of Brazilian radiopharmacy.

In the same year, RPH Central Pharma, the first centralized radiopharmacy in Brazil, was inaugurated in São Paulo.